Page last updated: 2024-10-29

inositol niacinate and Peripheral Arterial Disease

inositol niacinate has been researched along with Peripheral Arterial Disease in 2 studies

Peripheral Arterial Disease: Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Squires, H1
Simpson, E1
Meng, Y1
Harnan, S1
Stevens, J1
Wong, R1
Thomas, S1
Michaels, J1
Stansby, G1
BRANZI, G1
ANNINO, G1

Reviews

1 review available for inositol niacinate and Peripheral Arterial Disease

ArticleYear
A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.
    Health technology assessment (Winchester, England), 2011, Volume: 15, Issue:40

    Topics: Cilostazol; Cost-Benefit Analysis; Humans; Intermittent Claudication; Nafronyl; Nicotinic Acids; Pen

2011

Other Studies

1 other study available for inositol niacinate and Peripheral Arterial Disease

ArticleYear
[Therapy of peripheral arteriopathies with a compound with a base of inositol hexanicotinate].
    La Riforma medica, 1963, Jan-19, Volume: 77

    Topics: Inositol; Niacin; Nicotinic Acids; Peripheral Arterial Disease; Peripheral Vascular Diseases; Pyrido

1963